EUVIMEDEUVIMED entdecken
Open Access

Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaques

Pattaraporn Vanachayangkul, Chanikarn Kodchakorn, Winita Ta-Aksorn, Rawiwan Im-Erbsin, Anchalee Tungtaeng, Phornpimon Tipthara, Joel Tarning iD, Luis A Lugo-Roman, Mariusz Wojnarski, Brian A Vesely, Kevin C Kobylinski iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00181-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Pattaraporn Vanachayangkul und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand. Hauptthemen laut MEDLINE: Macaca mulatta, Ivermectin, Chloroquine, Aminoquinolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: US Military Infectious Disease Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ivermectin (IVM) could be used for malaria control as treated individuals are lethal to blood-feeding Anopheles , resulting in reduced transmission. Tafenoquine (TQ) is used to clear the liver reservoir of Plasmodium vivax and as a prophylactic treatment in high-risk populations. It has been suggested to use ivermectin and tafenoquine in combination, but the safety of these drugs in combination has not been evaluated. Early derivatives of 8-aminoquinolones (8-AQ) were neurotoxic, and ivermectin is an inhibitor of the P-glycoprotein (P-gp) blood brain barrier (BBB) transporter. Thus, there is concern that co-administration of these drugs could be neurotoxic. This study aimed to evaluate the safety and pharmacokinetic interaction of tafenoquine, ivermectin, and chloroquine (CQ) in Rhesus macaques. No clinical, biochemistry, or hematological outcomes of concern were observed. The Cambridge Neuropsychological Test Automated Battery (CANTAB) was employed to assess potential neurological deficits following drug administration. Some impairment was observed with tafenoquine alone and in the same monkeys with subsequent co-administrations. Co-administration of chloroquine and tafenoquine resulted in increased plasma exposure to tafenoquine. Urine concentrations of the 5,6 orthoquinone TQ metabolite were increased with co-administration of tafenoquine and ivermectin. There was an increase in ivermectin plasma exposure when co-administered with chloroquine. No interaction of tafenoquine on ivermectin was observed in vitro . Chloroquine and trace levels of ivermectin, but not tafenoquine, were observed in the cerebrospinal fluid. The 3′′- O -demethyl ivermectin metabolite was observed in macaque plasma but not in urine or cerebrospinal fluid. Overall, the combination of ivermectin, tafenoquine, and chloroquine did not have clinical, neurological, or pharmacological interactions of concern in macaques; therefore, this combination could be considered for evaluation in human trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macaca mulattaIvermectinChloroquineAminoquinolinesAntimalarialsDrug InteractionsAnimalsMaleFemaleATP Binding Cassette Transporter, Subfamily B, Member 1Blood-Brain Barrier

Stichwörter der Autor:innen

chloroquineivermectinmacaquepharmacokineticssafetytafenoquine

Substanzen

tafenoquineIvermectinChloroquineAminoquinolinesAntimalarialsATP Binding Cassette Transporter, Subfamily B, Member 1

Autor:innen und Institutionen

  • Department of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
  • Department of Veterinary Medicine, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
  • Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
  • Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Department of Entomology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.

ORCID-Profile: Joel Tarning, Kevin C Kobylinski

Förderung

  • US Military Infectious Disease Research Program

Zitieren

APA

Vanachayangkul, P., Kodchakorn, C., Ta-Aksorn, W., Im-Erbsin, R., Tungtaeng, A., Tipthara, P., Tarning, J., Lugo-Roman, L. A., Wojnarski, M., Vesely, B. A., & Kobylinski, K. C. (2024). Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaques. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00181-24

Vancouver

Vanachayangkul P, Kodchakorn C, Ta-Aksorn W, Im-Erbsin R, Tungtaeng A, Tipthara P, et al. Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaques. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00181-24

BibTeX
@article{Vanachayangkul2024,
  author = {Vanachayangkul, Pattaraporn and Kodchakorn, Chanikarn and Ta-Aksorn, Winita and Im-Erbsin, Rawiwan and Tungtaeng, Anchalee and Tipthara, Phornpimon and Tarning, Joel and Lugo-Roman, Luis A and Wojnarski, Mariusz and Vesely, Brian A and Kobylinski, Kevin C},
  title = {Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaques},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00181-24}
}
Kostenlos starten →